Save

Biobanking between the EU and Third Countries — Can Data Sharing Be Facilitated via Soft Regulatory Tools?

In: European Journal of Health Law
Author:
Santa Slokenberga Postdoctoral fellow, Lund University, Faculty of Law Sweden Researcher, Uppsala University, Centre for Research Ethics and Bioethics Sweden Lecturer, Faculty of Law, Riga Stradins University Latvia

Search for other papers by Santa Slokenberga in
Current site
Google Scholar
PubMed
Close
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

$40.00

Abstract

In biobanking, collaboration and data sharing contribute to building genomic research capacity, and have the potential to further scientific advances that ultimately can result in advances in clinical care. However, in the absence of common applicable legal frameworks that enable collaboration, capacity building is hindered. With the applicability of the General Data Protection Regulation, the obstacles to data sharing which involve export of data from European Union Member States to third countries are expected to grow, rendering the collaboration between the EU and third countries even more challenging. This article examines how, if at all, data sharing in biobank research between the EU and third countries could be facilitated via the use of soft regulatory tools. It argues that although the existing soft tools might not in itself be suitable for meeting all the GDPR requirements, they could be the basis on which to raise the area-specific data protection bar globally.

Content Metrics

All Time Past 365 days Past 30 Days
Abstract Views 354 190 49
Full Text Views 511 4 1
PDF Views & Downloads 416 8 3